相关期刊:《Journal of Chinese Pharmaceutical Sciences》《Acta Pharmacologica Sinica》《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》更多>>
supported in part by the National Natural Science Foundation of China(No.81372266);the National Science and Technology Major Project of the Ministry of Science and Technology of China(No.2011zx09101-001-03)
It has been reported that Ethaselen shows inhibitory effects on thioredoxin reductase(TrxR) activity and human tumor cell growth. In order to find an efficient way to reverse cisplatin resistance, we investigated th...
This work was supported in part by the National Natural Science Foundation (81372266) and the National Science and Technology Major Project, China (2011zx09101-001-03).
Thioredoxin reductase (TrxR) is a component of several redox-sensitive signaling cascades that mediate important biological processes such as cell survival, maturation, growth, migration and inhibition of apoptosis....
National Natural Science Foundation(Grant No.81372266);National Science and Technology Major Project,People’s Republic of China(Grant No.2011zx09101-001-03)
As a synthesized antineoplastic organoselenium compound, ethaselen is known to induce apoptosis in tumor cells via dose-dependent thioredoxin reductase (TrxR) inhibition. Thioredoxin, the multifunctional biological ...
National Science and Technology Major Project,Peoples’Republic of China(Grant No.2011zx09101-001-03)
Thioredoxin reductase (TrxR) is an important enzyme responsible for the removal of excess reactive oxygen species (ROS) in mammalian cells. This study aimed to investigate the roles of ROS in the anti-tumor effect...
Key Drug Innovation Project of China (Grant No. 2009ZX09102-031)
A novel ethaselen injection formulation has been developed in our laboratory. The objective of the present study was to establish and validate a high performance liquid chromatography (HPLC) method for the determina...
National Natural Science Foundation of China(Grant No.30472036)
Ethaselen, an organoselenium compound designed and synthesized in the School of Pharmaceutical Sciences, Peking University, has been entitled to independent intellectual property rights both at home and abroad. As one...
National Natural Science Foundation of China (Grant No.30472036).
The antitumor activities of ethaselen (BBSKE) in combination with cisplatin (CDDP) in vitro have been investigated in human stomach cancer cell line BGC 823 and human lung cancer cell line PG-BE1. MTT method was u...
National Natural Science Foundation of China (Grant No.30472036).
We investigated the redox status of H22 hepatocellular carcinoma xenografts treated with various doses of ethaselen, a novel anticancer drug targeting thioredoxin reductase (TrxR). The concentrations of low molecula...
National Natural Science Foundation of China (Grant No. 30472036);Beijing Natural Science Foundation (Grant No. 7021001)
The binding pattern of Ethaselen to bovine serum albumin (BSA) was studied by fluorescence spectroscopic technique and Autodock 3.0.5 analysis. The result showed that the binding constant K of Ethaselen and BSA is ...